Company Logo

milatuzumab

Agricultural Biotechnology

Updated on Feb 9, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for milatuzumab with ID of: 4038962
Recombinant chimeric (primate/human) antibody expressed in CHO binding to human CD4/p55. Clenoliximab is a monoclonal antibody against CD4. It acts as an immunomodulator and has been investigated for the treatment of rheumatoid arthritis. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD74. Milatuzumab is a monoclonal antibody for the treatment of multiple myeloma and other hematological malignancies.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.